ACADIA Pharma Shares Move Higher as JMP Boosted Price Target from $16 to $27

Loading...
Loading...
JMP Securities maintains ACADIA Pharmaceuticals Inc.
ACAD
with a Market Outperform and raises the price target from $16.00 to $27.00. The stock has opened up more than 4 percent higher. With the stock last trading at $19.45, the firm's new price target implies potential upside of about 39 percent.
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: NewsPrice TargetAnalyst Ratings
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...